Table 2.
Cox regression analysis of multivariate for RFS and OS of breast cancer patients.
| Variables | RFS | OS | ||
|---|---|---|---|---|
| validation cohort | 95%CI | p | 95%CI | p |
| RIS (high vs. low) | 0.079-0.870 | 0.029 | 0.083-0.920 | 0.036 |
| Estrogen receptor status(positive vs. negative) | 0.564-1.088 | 0.145 | 0.542-1.046 | 0.009 |
| Progesterone receptor status(positive vs. negative) | 0.607-1.162 | 0.293 | 0.610-1.168 | 0.306 |
| Human epidermal growth factor receptor2 status(positive vs. negative) | 0.572-3.835 | 0.419 | 0.547-3.655 | 0.474 |
| Laterality(left vs. right) | 0.379-2.407 | 0.922 | 0.389- 2.470 | 0.967 |
| Age(≥60 vs. <60) | 0.429-5.126 | 0.533 | 0.446-5.322 | 0.495 |